Security key
702712100
Passage BIO, Inc. - Common Stock, par value $0.0001 per share (PASG)
CUSIP: 702712100
Q2 2021 13F Holders as of 30 Jun 2021
- Security type / class
- Equity / Common Stock, par value $0.0001 per share
- Total 13F shares
- 42,094,204
- Total 13F value
- $557,333,406
- Share change
- -401,154
- SEC-reported price per share
- $13.24
- Number of holders
- 99
- Value change
- -$6,360,822
- Number of buys
- 62
- Number of sells
- 26
- Shares outstanding
- 3,208,376
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2021
Institutions
99
Top holders
10
PASG full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q4 2025
Passage BIO, Inc. SEC filings
Passage BIO, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 702712100
Recent filing periods:
Ownership snapshot
Top reported holders of PASG - Passage BIO, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
FMR LLC
Disclosed value leader
FMR LLC
Comparable rows
0/15
Latest evidence
31 Mar 2021
13F
Highest disclosed value: $141,147,000
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
FMR LLC has the largest disclosed position value at $141.15M.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens FMR LLC's linked filing trail.
Disclosed position value
Top 5
FMR LLC
$141.15M
ORBIMED ADVISORS LLC
$121.71M
FRAZIER MANAGEMENT LLC
$87.56M
Versant Venture Management, LLC
$86.7M
BlackRock Finance, Inc.
$52.47M
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| FMR LLC |
13F
Company
|
—
denominator unverified
|
$141,147,000
8,074,687 shares
|
— | 31 Mar 2021 |
| ORBIMED ADVISORS LLC |
13F
Company
|
—
denominator unverified
|
$121,711,000
6,962,899 shares
|
— | 31 Mar 2021 |
| FRAZIER MANAGEMENT LLC |
13F
Company
|
—
denominator unverified
|
$87,561,000
5,009,219 shares
|
— | 31 Mar 2021 |
| Versant Venture Management, LLC |
13F
Company
|
—
denominator unverified
|
$86,697,000
4,959,769 shares
|
— | 31 Mar 2021 |
| BlackRock Finance, Inc. |
13F
Company
|
—
denominator unverified
|
$52,468,000
3,001,646 shares
|
— | 31 Mar 2021 |
| New Leaf Venture Partners, L.L.C. |
13F
Company
|
—
denominator unverified
|
$43,664,000
2,497,922 shares
|
— | 31 Mar 2021 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2021
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
99
Shares
42,094,204
Rows available
99
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2021 vs Q1 2021 Across Filers
Q1 2021 holders
88
Q2 2021 holders
99
Holder diff
11
| Investor | Q1 2021 Shares | Q2 2021 Shares | Share Diff | Share Chg % | Q1 2021 value | Q2 2021 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend